|
Reference
|
Year
|
Design
|
EI (Region)
|
N
|
BG (M/F, agea)
|
NBG (M/F, agea)
|
Score
|
|---|
|
Kakaei [4]
|
2015
|
RCT
|
2013–2013 (Iran)
|
30
|
14 (10/5, 57)
|
15 (10/5, 55)
|
2
|
|
Hwang [5]
|
2016
|
RCT
|
2013–2014 (Korea)
|
60
|
30 (19/11, 69)
|
30 (19/11, 63)
|
3
|
|
Fujieda [6]
|
2017
|
RCT
|
2011–2016 (Japan)
|
68
|
34 (20/14, 66)
|
34 (24/10, 72)
|
3
|
|
Hochwald [11]
|
2010
|
NRCT
|
2001–2006 (USA)
|
105
|
70 (−/−, 65)
|
35 (−/−, 4)
|
8
|
|
Nikfarjam [12]
|
2012
|
NRCT
|
2009–2011 (Australia)
|
44
|
24 (15/9, 67)
|
20 (14/6, 70)
|
7
|
|
Cordesmeye [13]
|
2014
|
NRCT
|
2004–2011 (German)
|
45
|
51 (27/24, −)
|
62 (32/30, −)
|
6
|
|
Wang [14]
|
2014
|
NRCT
|
2008–2012 (China)
|
62
|
32 (17/15, 58)
|
30 (19/11, 57)
|
8
|
|
Zhang [15]
|
2014
|
NRCT
|
2009–2013(China)
|
395
|
347 (271/73, 57)
|
48 (22/26, 58)
|
8
|
|
Xu [16]
|
2015
|
NRCT
|
2000–2013 (China)
|
407
|
206 (124/82, 57)
|
201 (128/73, 58)
|
7
|
|
Meng [17]
|
2015
|
NRCT
|
2009–2013 (China)
|
203
|
98 (57/41, 62)
|
105 (68/37, 60)
|
8
|
|
Watanabe [18]
|
2015
|
NRCT
|
2008–2013 (Japan)
|
185
|
98 (57/41, 67)
|
87 (47/40, 70)
|
8
|
- EI enrolment interval, BG Braun group, NBG non-Braun group, RCT randomised controlled trial, NRCT non-RCT, M male, F female, ayears
